Skip to main content
Premium Trial:

Request an Annual Quote

Caliper, Shimadzu Settle Patent Litigation

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences today said that it had reached a settlement agreement with Shimadzu over a patent infringement suit it had filed against the Japanese firm two months ago.

Caliper had filed the suit in January in the US District Court for the Eastern District of Texas, alleging that Shimadzu's MCE-202 MultiNA instrument system, a microchip-based electrophoresis system that performs DNA and RNA size confirmation and quantitation, infringed 11 patents covering its LabChip technology.

According to Hopkinton, Mass.-based Caliper, Shimadzu denied infringing the patents, but it agreed to discontinue sales of the MultiNA system in the US. Further terms of the settlement agreement were not disclosed.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.